For example, the loss of MSH2 and/or MSH6 expression indicates a suspicion of Lynch syndrome, whereas the loss of MLH1 and PMS2 expression requires further investigation to assess the presence of a BRAF mutation or hypermethylation of the MLH1 gene promoter region [37]. This evidence concerns the gene MLH1 and Lynch syndrome.